Ref.: BL-RE-091424Manufacturer ref.: ERA59RBX5 5 x 96 tests
€2,950.00 excl. VAT
Rat VEGFR1 quantitates rat VEGFR1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat VEGFR1.
Accession number
Ai323757; Embryonic receptor kinase 2; Emrk2; FLT; Flt1; FLT-1; Tyrosine kinase 1 liée au FMS ; tyrosine kinase 1 similaire au FMS ; tyrosine kinase 1 liée au FMS ; tyrosine kinase 1 liée au fms (récepteur du facteur de croissance endothélial vasculaire/du facteur de perméabilité vasculaire) ; FRT ; i21 ; sFlt1 ; VEGFR soluble 1 ; SVEGFR 1; Tyrosine-protéine kinase FRT; récepteur de la tyrosine-protéine kinase FLT; récepteur du facteur de croissance endothélial vasculaire 1; récepteur du facteur de croissance endothélial vasculaire 1; récepteur du facteur de perméabilité vasculaire; VEGF R1; VEGFR1; VEGFR-1
Dose range
0.41 to 100 ng/ml
Sensitivity of the dosage
0.41 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Rat VEGFR1 quantitates rat VEGFR1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat VEGFR1.
Rat VEGFR1 quantitates rat VEGFR1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat VEGFR1.
Tyrosine-protein kinase, which acts as a cell surface receptor for VEGFA, VEGFB and PGF, and plays an essential role in the development of embryonic vasculature, regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxia, and invasion of cancer cells. Can play an essential role as a negative regulator of embryon langiogenesis by inhibiting the excessive proliferation of endothelial cells. May promote the proliferation, survival and langiogenesis of endothelial cells in adulthood. Its function of promoting cell proliferation appears to be specific to the cell type. Promotes the proliferation of endothelial cells by PGF, the proliferation of certain types of cancer cells, but does not promote the proliferation of normal fibroblasts (in vitro). Has a very high affinity for VEGFA and relatively low protein kinase activity; can function as a negative regulator of VEGFA signaling by limiting the amount of free VEGF and preventing its binding to KDR.
Sensitivity
Sensitivity of dosage: 0.41 ng/ml.
Measurement range
Dose range: 0.41 to 100 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: VEGF receiver 1.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).